GILD vs REGN
GILD 与 REGN 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | GILDGILEAD SCIENCES, INC. | REGNREGENERON PHARMACEUTICALS, INC. |
|---|---|---|
| 市值 | $211.34B | — |
| 市盈率(TTM) | 25.1 | 21.3 |
| 市净率 | 16.21 | — |
| 市销率 | 7.1x | — |
| 股息率 | 1.89% | — |
| 营收 | $30.99B(TTM) | $16.90B(TTM) |
| 营收同比增长 | 2.4% | 1.0% |
| 净利润 | -$3.86B(TTM) | $4.82B(TTM) |
| 净利同比增长 | 1672.9% | 2.1% |
| 每股收益(稀释) | $-3.13(TTM) | $45.24(TTM) |
| 息税前利润率 | 34.0% | 24.9% |
| 净资产收益率 | 65.3% | 13.4% |
| 投入资本回报率 | 25.7% | 9.2% |
| 一年总回报 | +42.7% | +47.6% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:GILD vs REGN
| 指标 | GILD | REGN |
|---|---|---|
| 期末价值 | $29.3K | $27.8K |
| 总回报 | +192.6% | +177.8% |
| 年化收益 (CAGR) | +10.9% | +10.4% |
| 波动率 | 25.6% | 32.3% |
| 夏普比率 | 0.37 | 0.34 |
| 索提诺比率 | 0.55 | 0.50 |
| 最大回撤 | -30.5% | -59.7% |
基于 2600 个共同交易日,2016-06-30 → 2026-11-02 · 无风险利率 4.21%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)